Insider Transactions in Q2 2022 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
2,327
-0.82%
|
$0
$0.64 P/Share
|
|
Jun 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
2,403
-2.76%
|
$0
$0.64 P/Share
|
|
Jun 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
2,650
-2.51%
|
$0
$0.64 P/Share
|
|
Jun 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
2,327
-2.5%
|
$0
$0.64 P/Share
|
|
Jun 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
218
-6.33%
|
$0
$0.64 P/Share
|
|
Jun 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,504
-9.27%
|
$0
$0.64 P/Share
|
|
Jun 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,062
+1.75%
|
-
|
|
Jun 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,062
+5.5%
|
-
|
|
Jun 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,062
+4.57%
|
-
|
|
Jun 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,062
+5.16%
|
-
|
|
Jun 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
507
+12.84%
|
-
|
|
Jun 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,896
+15.15%
|
-
|
|
May 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
4,570
-2.76%
|
$4,570
$1.97 P/Share
|
|
May 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,252
-2.09%
|
$4,252
$1.97 P/Share
|
|
May 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
76
-2.52%
|
$76
$1.97 P/Share
|
|
May 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,700
-6.18%
|
$1,700
$1.97 P/Share
|
|
May 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
4,570
-2.57%
|
$4,570
$1.97 P/Share
|
|
May 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
3,733
-0.67%
|
$3,733
$1.97 P/Share
|
|
May 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+5.82%
|
-
|
|
May 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+3.95%
|
-
|
|
May 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
181
+5.67%
|
-
|
|
May 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,374
+10.93%
|
-
|
|
May 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+5.45%
|
-
|
|
May 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+1.48%
|
-
|
|
Apr 04
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
7
-0.25%
|
$14
$2.66 P/Share
|
|
Apr 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
16
+0.56%
|
-
|